Shares of Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) dropped 39.5% during trading on Monday . The company traded as low as $4.11 and last traded at $4.42. Approximately 186,087 shares changed hands during mid-day trading, an increase of 540% from the average daily volume of 29,083 shares. The stock had previously closed at $7.30.
Sol-Gel Technologies Trading Up 1.6 %
The company has a market cap of $21.87 million, a price-to-earnings ratio of -23.09 and a beta of 1.11. The company has a fifty day moving average price of $5.81 and a two-hundred day moving average price of $6.70.
Institutional Investors Weigh In On Sol-Gel Technologies
An institutional investor recently bought a new position in Sol-Gel Technologies stock. Raymond James Financial Inc. bought a new stake in shares of Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The fund bought 108,990 shares of the company's stock, valued at approximately $101,000. Raymond James Financial Inc. owned approximately 0.39% of Sol-Gel Technologies as of its most recent filing with the SEC. Institutional investors and hedge funds own 26.18% of the company's stock.
Sol-Gel Technologies Company Profile
(
Get Free Report)
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.
Further Reading
Before you consider Sol-Gel Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sol-Gel Technologies wasn't on the list.
While Sol-Gel Technologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
